The transcription factor p53 can induce apoptosis and cell cycle arrest in response to cellular distress. Cancer cells often display increased cell survival. In most cases, this is due to a p53-related defect, such as mutation, deletion, degradation, or sequestration. HDM2 and HDMX are homologous proteins that regulate the function of p53, and their over-expression can lead to an ineffective p53 response. Various inhibitors, including hydrocarbon stabilized alpha-helices of p53 (SAH-p53s), have been developed to target HDM2 and HDMX and restore functionality to the p53 pathway. It has been recently found that SAH-p53 factors also elicit cell death responses in the absence of transcriptionally active p53. In order to investigate other potential targets of SAH-p53, a protocol was developed based on a paper by Craig Braun 11 which discusses a mechanism utilizing photoactivatable amino substitutions to capture binding partners covalently. Using this protocol, p53-derived stapled peptides were found to bind selectively to p53’s known target, HDM2 as well as other unknown proteins. The various p53-derived stapled peptides were utilized to obtain further insight into the p53-derived stapled peptide targets.